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Protective effect of erdosteine on erythrocyte deformability
in a rat model of lower limb ischemia/reperfusion injury
1,

2

3

1

4

Abdullah ÖZER *, Hüseyin DEMİRTAŞ , Faruk Metin ÇOMU , Dilek ERER , Yiğit KILIÇ ,
1
5
6
1
Barış MARDİN , Mustafa ARSLAN , Ayşegül KÜÇÜK , G. Levent OKTAR
1
Department of Cardiovascular Surgery, Faculty of Medicine, Gazi University, Ankara, Turkey
2
Department of Cardiovascular Surgery, Yüksek İhtisas Hospital, Kırıkkale, Turkey
3
Department of Physiology, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkey
4
Department of Cardiovascular Surgery, Iğdır State Hospital, Iğdır, Turkey
5
Department of Anesthesiology and Reanimation, Faculty of Medicine, Gazi University, Ankara, Turkey
6
Department of Physiology, Faculty of Medicine, Dumlupınar University, Kütahya, Turkey
Received: 23.06.2017

Accepted/Published Online: 07.12.2017

Final Version: 23.02.2018

Background/aim: The protective effect of erdosteine on local and distant organ injury due to ischemia/reperfusion has been well
documented but its effect on erythrocyte deformability needs further investigation. Our aim was to investigate the effect of erdosteine
on erythrocyte deformability in the infrarenal aorta of rats undergoing ischemia/reperfusion.
Materials and methods: Our study was conducted with 18 Wistar albino rats. Rats were divided into 3 groups: a randomized control
group (group ‘control’, n = 6), an ischemia/reperfusion group without erdosteine (group ‘ischemia/reperfusion’, n = 6), and an ischemia/
reperfusion group with erdosteine at 150 mg kg–1, intraperitoneally (group ‘ischemia/reperfusion – erdosteine’, n = 6). Packs of
erythrocytes were prepared from heparinized blood samples and deformability measurements were conducted.
Results: Comparisons of the control and ischemia/reperfusion – erdosteine groups revealed similar results (P = 0.051). The values of
the ischemia/reperfusion group were significantly higher than those of the control and ischemia/reperfusion – erdosteine groups (P <
0.0001 and P = 0.024, respectively). Relative resistance, a marker of erythrocyte deformability, was increased significantly by ischemia/
reperfusion compared to the control and ischemia/reperfusion – erdosteine groups (P < 0.05).
Conclusion: We detected unfavorable effects of ischemia/reperfusion on erythrocyte deformability, which may lead to disturbance
in blood flow and hence tissue perfusion in the infrarenal rat aorta. We also found that erdosteine had beneficial effects by reversing
undesirable effects of ischemia/reperfusion. However, these promising results should be further supported by more detailed studies with
larger volumes.
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1. Introduction
Damage to cells after reperfusion of previously viable
ischemic tissues in the lower extremities is a frequent and
serious clinical event. If blood flow is reestablished after
reperfusion, substances produced as a result of oxidation
may unexpectedly induce increased rates of mortality and
morbidity because of systemic complications. Following
local edema and muscle tissue necrosis, systemic
inflammatory response syndrome and multiple organ
failure (e.g., kidney, respiratory, and circulatory systems)
generally occur as reperfusion accelerates (1–5).
Erdosteine (N-carboxymethylthioacetyl-homocysteine
thiolactone), which is a mucolytic agent, contains two
* Correspondence: dr-abdozer@hotmail.com

sulfhydryl groups that are available for free radical
scavenging (6). Erdosteine has been used to protect against
and cure ischemia/reperfusion (I/R) injury in many organs
(1,7–10).
Advantages of erdosteine use in cases of I/R to prevent
local and distal tissue injury have been well reported so far.
However, not much is known about its protective effect on
erythrocyte deformability following I/R injury.
The primary aim of this study was to investigate the
effect of erdosteine on lower extremity muscle ischemia
and subsequent I/R injury, which may happen frequently
after the tourniquet method.
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Erythrocyte deformability was measured by a constantcurrent filtrometer system. Samples were prepared as
10 mL of erythrocyte suspension and PBS buffer before
measurement. The infusion pump was set at 1.5 mL/
min for a constant rate of flow. A 28-mm nucleoporin
polycarbonate filter with a 5-µm pore diameter was used.
Pressure changes while the erythrocytes passed through
the filter were detected by the pressure transducer and the
data were transferred to a computer with the help of the
MP30 system (BIOPAC Systems Inc., USA). At different
times pressure changes were measured by using relevant
computer programs for calculations. Pressure calibration
of the system was performed each time before measuring
the samples. After the buffer (PT) was passed through
the filtration system, the erythrocytes (PE) were passed
through secondly. Pressure variations were measured. By
relating the pressure value of the erythrocyte suspension
to the pressure value of the buffer, the relative refractory
period value (Rrel) was calculated. The deformability
index was interpreted such that as Rrel was increasing the
ability of erythrocyte deformability was affected adversely
(7,8).
2.3. Statistical analysis
All data were processed by variance analysis using SPSS
17.0 for Windows (SPSS Inc., USA). P < 0.05 was considered
statistically significant. The data were expressed as mean
± standard deviation. Variance analysis and the Kruskal–
Wallis test were used to evaluate the data. Mann–Whitney
U tests with Bonferroni corrections were used to evaluate
the variables with significance.
3. Results
This study showed that relative resistance, a marker of
erythrocyte deformability, was increased significantly by
I/R compared to the control and I/R-E groups (P < 0.05;
Figure).
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2. Materials and methods
2.1. Animals and experimental protocol
This study was carried out in the Gazi University Physiology
Laboratory with the approval of the Gazi University Ethical
Committee of Experimental Animals (20/06/2016-E.7657
7GÜET-16.044). All employed methods were in agreement
with approved basics of the Guide for the Care and Use of
Laboratory Animals.
The present study was undertaken with 18 albino
Wistar rats with body weights ranging between 250 and
300 g and aged between 10 and 12 weeks, raised under
identical environmental conditions. The rats were kept
at 20–21 °C with a 12:12-h light:dark photoperiod and
could access food freely until 2 h before the induction
of anesthesia. The 18 Wistar albino rats were randomly
divided into three groups, each containing 6 rats. Median
laparotomy was done under general anesthesia.
In the control group, median laparotomy was performed
alone without any additional surgical intervention. After 2
h, at the end of the procedure, a blood sample was taken
from the infrarenal segment of the aorta and the animals
were sacrificed.
In the I/R group, median laparotomy was performed
as well. We clamped the infrarenal part of the aorta with
an atraumatic clamp for 2 h. Then we removed the clamp
and allowed reperfusion for 2 more h. In the end, rats were
sacrificed after taking blood samples from the infrarenal
segment of the aorta.
In the I/R group with erdosteine (I/R-E), similar
steps were performed, but additionally, before the
ischemia period, erdosteine was given (150 mg kg–1)
intraperitoneally for 30 min. Rats were sacrificed at the end
of the reperfusion period, which lasted 2 h, after collecting
blood samples from the infrarenal segment of the aorta.
All the rats were given ketamine at 100 mg kg–1
intraperitoneally and blood samples were obtained.
Heparinized total blood samples were used to prepare
erythrocyte packs. Deformability measurements were
done using erythrocyte suspensions with 5% hematocrit
in phosphate-buffered saline (PBS) buffer.
2.2. Deformability measurements
To prevent hemolysis, samples of blood were collected very
carefully and the measurement process was done rapidly.
Collected blood was centrifuged at 1000 rpm for 10 min.
Blood plasma in the upper phase and the buffy coat were
removed. Isotonic PBS buffer was added to collapsing
erythrocytes and this mixture was centrifuged at 1000 rpm
for 10 min. Liquid from the upper surface was taken. The
washing process was repeated three times and finally pure
red cell packs were obtained. Erythrocyte suspensions with
5% hematocrit in PBS buffer were used for deformability
measurements. Erythrocytes were collected and then
deformability measurements were done at 22 °C
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Figure. Erythrocyte deformability index values of the groups.
Each bar represents the mean ± standard deviation.
*: P < 0.05 compared to the I/R group.
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There were significant differences between the groups
according to the comparisons with one-way ANOVA
test (F: 14.937, P < 0.0001). The results obtained after
corrections with the Tukey HSD test were as follows:
comparisons of the control and I/R-E groups revealed
similar results (P = 0.051). The values of the I/R group
were significantly higher than those of the control and
I/R-E groups (P < 0.0001 and P = 0.024, respectively).
4. Discussion
Erdosteine inhibits the clustering and activation of platelets.
It enhances microvascular perfusion and fibrinolytic
activity, inhibits leukocyte/vessel wall interaction, and
helps maintain endothelial cell integrity. Ischemic damage
results from a decrease in the blood flow of an organ and
reperfusion injury results from the enhanced generation
of oxygen radicals. These effects together improve the
outcome of patients with critical limb ischemia (6,11,12).
Erdosteine is a thiol derivative containing two blocked
sulfhydryl groups in the aliphatic side chain, which
become free only after hepatic metabolization. Metabolites
of erdosteine have two sulfhydryl groups and they take
part in free radical scavenging and antioxidant activity
(13). Free radical scavenging properties of erdosteine have
been shown in experimental and clinical studies (1,6,7,11).
Lipid peroxidation is reduced by erdosteine with direct
free radical scavenging properties. This was shown by
reducing the level of malondialdehyde (MDA), the end
product of lipid peroxidation, by the administration of
erdosteine (14).
For migration of oxygen and vital molecules to the
final organ capillaries and clearance of metabolic wastes,
erythrocytes must be able to extend and curve and have
the capability to move in these areas. This capacity,
known as “deformability”, becomes more important in

microcirculation. Altered erythrocyte deformability
changes not only the oxygen delivery capacity of the
erythrocytes but also the survival of the circulating
erythrocytes (15–17).
In our study, relative resistance, a marker of erythrocyte
deformability, was increased significantly by I/R compared
to the control and I/R-E groups (P < 0.05; Figure). As
comparisons of the values of the control and I/R-E
groups were similar (P = 0.051), values of the I/R group
were significantly higher than those of the control and
I/R-E groups (P < 0.0001 and P = 0.024, respectively). We
observed that erdosteine treatment had a protective effect
in reducing the oxidative stress after hind limb ischemia in
this animal model. The aim of this study was to investigate
the antioxidant protective effect of erdosteine on hind limb
I/R injury in rats and these results were encouraging.
In a previous study, 150 mg/kg erdosteine was found
to be effective in preventing local tissue injury following
testicular torsion (18). In another study, Yurdakul et al.
reported that levels of MDA and xanthine oxidase were
decreased by erdosteine treatment (19). To our knowledge,
this is the first study demonstrating the protective effect of
erdosteine on I/R injury by erythrocyte deformability in
an experimental lower limb I/R injury rat model.
In addition to these data, our findings indicate that in
rats undergoing I/R erythrocyte is deformability impaired
and this impairment leads to disturbed microvascular
perfusion and related problems. We think that
measurement of erythrocyte deformability could be useful
as a parameter in cases of I/R. We also did not observe a
negative effect of erdosteine on maintaining erythrocyte
deformability during periods of I/R, but we still think
these promising results should be further supported by
more detailed studies with larger volumes.
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